|
1
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Levanon K, Crum C and Drapkin R: New
insights into the pathogenesis of serous ovarian cancer and its
clinical impact. J Clin Oncol. 26:5284–5293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thigpen JT, Aghajanian CA, Alberts DS, et
al: Role of pegylated liposomal doxorubicin in ovarian cancer.
Gynecol Oncol. 96:10–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aguirre-Ghiso JA: Models, mechanisms and
clinical evidence for cancer dormancy. Nat Rev Cancer. 7:834–846.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhattacharyya S and Khanduja KL: New hope
in the horizon: cancer stems cells. Acta Biochim Biophys Sin
(Shanghai). 42:237–242. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pelayo R, Miyazaki K, Huang J, et al: Cell
cycle quiescence of early lymphoid progenitors in adult bone
marrow. Stem Cells. 24:2703–2713. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yahata T, Muguruma Y, Yumino S, et al:
Quiescent human hematopoietic stem cells in the bone marrow niches
organize the hierarchical structure of hematopoiesis. Stem Cells.
26:3228–3236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar
|
|
9
|
Morel AP, Lièvre M, Thomas C, et al:
Generation of breast cancer stem cells through
epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hellsten R, Johansson M, Dahlman A,
Sterner O and Bjartell A: Galiellalactone inhibits stem cell-like
ALDH-positive prostate cancer cells. PLoS One. 6:e221182011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Belton A, Gabrovsky A, Bae YK, et al:
HMGA1 induces intestinal polyposis in transgenic mice and drives
tumor progression and stem cell properties in colon cancer cells.
PLoS One. 7:e300342012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rosen JM and Jordan CT: The increasing
complexity of the cancer stem cell paradigm. Science.
324:1670–1673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dubeau L: The cell of origin of ovarian
epithelial tumours. Lancet Oncol. 9:1191–1197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bapat SA: Human ovarian cancer stem cells.
Reproduction. 140:33–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lendahl U, Zimmerman LB and McKay RD: CNS
stem cells express a new class of intermediate filament protein.
Cell. 60:585–595. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishiwata T, Matsuda Y and Naito Z: Nestin
in gastrointestinal and other cancers: effects on cells and tumor
angiogenesis. World J Gastroenterol. 17:409–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Jong J and Looijenga LH: Stem cell
marker OCT3/4 in tumor biology and germ cell tumor diagnostics:
history and future. Crit Rev Oncog. 12:171–203. 2006.PubMed/NCBI
|
|
18
|
Hombach-Klonisch S, Paranjothy T, Wiechec
E, et al: Cancer stem cells as targets for cancer therapy: selected
cancers as examples. Arch Immunol Ther Exp (Warsz). 56:165–180.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bapat SA, Mali AM, Koppikar CB and Kurrey
NK: Stem and progenitor-like cells contribute to the aggressive
behavior of human epithelial ovarian cancer. Cancer Res.
65:3025–3029. 2005.PubMed/NCBI
|
|
20
|
Sayed SI, Dwivedi RC, Katna R, et al:
Implications of understanding cancer stem cell (CSC) biology in
head and neck squamous cell cancer. Oral Oncol. 47:237–243. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yasui W, Sentani K, Sakamoto N, et al:
Molecular pathology of gastric cancer: research and practice.
Pathol Res Pract. 207:608–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsuda Y, Kure S and Ishiwata T: Nestin
and other putative cancer stem cell markers in pancreatic cancer.
Med Mol Morphol. 45:59–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma L, Lai D, Liu T, et al: Cancer
stem-like cells can be isolated with drug selection in human
ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin
(Shanghai). 42:593–602. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reber L, Da Silva CA and Frossard N: Stem
cell factor and its receptor c-Kit as targets for inflammatory
diseases. Eur J Pharmacol. 533:327–340. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yue Z, Jiang TX, Widelitz RB and Chuong
CM: Mapping stem cell activities in the feather follicle. Nature.
438:1026–1029. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martin-Padura I, Marighetti P, Agliano A,
et al: Residual dormant cancer stem-cell foci are responsible for
tumor relapse after antiangiogenic metronomic therapy in
hepatocellular carcinoma xenografts. Lab Invest. 92:952–966. 2012.
View Article : Google Scholar
|
|
27
|
Gao MQ, Choi YP, Kang S, Youn JH and Cho
NH: CD24+ cells from hierarchically organized ovarian
cancer are enriched in cancer stem cells. Oncogene. 29:2672–2680.
2010.PubMed/NCBI
|
|
28
|
Patel P and Chen EI: Cancer stem cells,
tumor dormancy, and metastasis. Front Endocrinol (Lausanne).
3:1252012.PubMed/NCBI
|
|
29
|
Páez D, Labonte MJ, Bohanes P, et al:
Cancer dormancy: a model of early dissemination and late cancer
recurrence. Clin Cancer Res. 18:645–653. 2012.PubMed/NCBI
|
|
30
|
Rabik CA and Dolan ME: Molecular
mechanisms of resistance and toxicity associated with platinating
agents. Cancer Treat Rev. 33:9–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martin LP, Hamition TC and Schilder RJ:
Platinum resistance: the role of DNA repair pathways. Clin Cancer
Res. 14:1291–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kusumbe AP and Bapat SA: Cancer stem cells
and aneuploid populations within developing tumors are the major
determinants of tumor dormancy. Cancer Res. 69:9245–9253. 2009.
View Article : Google Scholar
|
|
33
|
Fleuren GJ, Gorter A, Kuppen PJ, Litvinov
S and Warnaar SO: Tumor heterogeneity and immunotherapy of cancer.
Immunol Rev. 145:91–122. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yaqui-Beltrán A, He B and Jablons DM: The
role of cancer stem cells in neoplasia of the lung: past, present
and future. Clin Transl Oncol. 10:719–725. 2008.PubMed/NCBI
|
|
36
|
Shackleton M: Normal stem cells and cancer
stem cells: similar and different. Semin Cancer Biol. 20:85–92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Friel AM, Sergent PA, Patnaude C, et al:
Functional analyses of the cancer stem cell-like properties of
human endometrial tumor initiating cells. Cell Cycle. 7:242–249.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li C, Heidt DG, Dalerba P, et al:
Identification of pancreatic cancer stem cells. Cancer Res.
67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gilbertson RJ and Graham TA: Cancer:
Resolving the stem-cell debate. Nature. 488:462–463. 2012.
View Article : Google Scholar : PubMed/NCBI
|
